EA201791448A1 - ANESTHETIC BASED ON TETRAKAINE - Google Patents

ANESTHETIC BASED ON TETRAKAINE

Info

Publication number
EA201791448A1
EA201791448A1 EA201791448A EA201791448A EA201791448A1 EA 201791448 A1 EA201791448 A1 EA 201791448A1 EA 201791448 A EA201791448 A EA 201791448A EA 201791448 A EA201791448 A EA 201791448A EA 201791448 A1 EA201791448 A1 EA 201791448A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tetrakaine
molars
tetracaine
methods
present
Prior art date
Application number
EA201791448A
Other languages
Russian (ru)
Inventor
Марк Дэвид Коллар
Original Assignee
СТ. РЕНАТУС, ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by СТ. РЕНАТУС, ЭлЭлСи filed Critical СТ. РЕНАТУС, ЭлЭлСи
Publication of EA201791448A1 publication Critical patent/EA201791448A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007—Syringe-type or piston-type sprayers or atomisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00—Local anaesthesia; Hypothermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/008—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised by squeezing, e.g. using a flexible bottle or a bulb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/048—Anaesthetics

Abstract

Настоящее изобретение связано с анестезирующими составами на основе тетракаина и со способами их применения. Настоящее изобретение также связано со стоматологическими анестезирующими составами на основе тетракаина и со способами обезболивания верхних задних моляров верхнечелюстной зубной дуги и тканей вокруг верхнечелюстных задних моляров, включая дистальную половину первого моляра, второго и третьего моляров с применением этих составов.The present invention relates to tetracaine based anesthetic formulations and methods for their use. The present invention is also associated with tetracaine-based dental anesthetics and methods of anesthetizing the upper posterior molars of the maxillary dental arch and the tissues around the maxillary posterior molars, including the distal half of the first molar, second and third molars using these compositions.

EA201791448A 2014-12-23 2015-12-23 ANESTHETIC BASED ON TETRAKAINE EA201791448A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462096287P 2014-12-23 2014-12-23
PCT/US2015/000209 WO2016105482A1 (en) 2014-12-23 2015-12-23 Tetracaine-based anesthetic

Publications (1)

Publication Number Publication Date
EA201791448A1 true EA201791448A1 (en) 2017-11-30

Family

ID=55237886

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791448A EA201791448A1 (en) 2014-12-23 2015-12-23 ANESTHETIC BASED ON TETRAKAINE

Country Status (11)

Country Link
EP (1) EP3236941A1 (en)
JP (1) JP2017538777A (en)
KR (1) KR20170102892A (en)
CN (1) CN107249568A (en)
AU (1) AU2015371291A1 (en)
BR (1) BR112017013373A2 (en)
CA (1) CA2971156A1 (en)
EA (1) EA201791448A1 (en)
IL (1) IL253125A0 (en)
MX (1) MX2017008516A (en)
WO (1) WO2016105482A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019191200A1 (en) 2018-03-27 2019-10-03 American Genomics, Llc Method and formulation for producing anesthesia of internal aspect of eye wall by topical application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580282B2 (en) * 2009-04-03 2013-11-12 St. Renatus, Llc Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration

Also Published As

Publication number Publication date
EP3236941A1 (en) 2017-11-01
WO2016105482A9 (en) 2017-08-03
BR112017013373A2 (en) 2018-01-02
KR20170102892A (en) 2017-09-12
IL253125A0 (en) 2017-08-31
MX2017008516A (en) 2017-09-19
JP2017538777A (en) 2017-12-28
CN107249568A (en) 2017-10-13
CA2971156A1 (en) 2016-06-30
AU2015371291A9 (en) 2017-08-24
AU2015371291A1 (en) 2017-08-03
WO2016105482A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
CY1118813T1 (en) PHARMACEUTICAL COMPOSITIONS OF TRAMADOL AND COXYL-CYLINDERS
CY1118379T1 (en) DISEASES OF USVITIS C
GT201200258A (en) COMPOSITIONS OF ANTI-FACTOR ANTI-FACTOR OF NERVOUS GROWTH (NGF)
EA201890654A1 (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF THE HUMAN IMMUNODEFICIENCY VIRUS
EA201992116A1 (en) PHARMACEUTICAL COMPOSITIONS OF FLOROGLUCINOL AND TRIMETHYLFLOROGLUCINOL
CL2017003066A1 (en) Compositions of amorphous calcium carbonate for administration by inhalation, sublingual or buccal
EA201171215A1 (en) DENTAL ANESTHETIC MEANS FOR INTRANASAL ADMINISTRATION, CONTAINING TETRAKAINE AND VASOCONSTRIKTOR
CY1116234T1 (en) Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2 / 3 conformers
UY36257A (en) "IMIDAZOPIRIDAZINE COMPOUNDS".
CY1120906T1 (en) OXPRENOLOL COMPOSITIONS FOR THE TREATMENT OF CANCER
BR112016024176A2 (en) oral care compositions having improved stability
CO2017003263A2 (en) Pharmaceutical composition based on anamorelin having activity on cachexia caused by cancer
CY1121063T1 (en) INHIBITORS OF ALDOSTERONE COMPOSITION
CY1121141T1 (en) COMPOSITION OF ORAL DISPOSABLE FILM INCLUDING ENAPRIL FOR THE TREATMENT OF HYPERTENSION IN PEDIATRIC POPULATION
CY1116158T1 (en) Substituted 2-oxo- and 2-thiooxy-dihydroquinoline-3-carboxamides as KCNQ2 / 3 modulators
EA201791448A1 (en) ANESTHETIC BASED ON TETRAKAINE
EA201490233A1 (en) STABLE MEDICAL FORMS OF ARTEROLANA AND PIPERAHIN
CY1118255T1 (en) Substituted 6-amino-nicotinamides which carry a group containing KCNQ2 / 3 modulators
RU2013128858A (en) METHOD FOR TREATING DENTAL CARIES
NZ740627A (en) Oral suspension for treating eosinophilic esophagitis
TR201716203A1 (en) New umeclidinium formulations.
EA201892095A1 (en) CYCLIC DYNUCLEOTIDE COMPOUNDS AND METHODS OF THEIR APPLICATION
PH12015502305A1 (en) Use of pidotimod to treat inflammatory bowel disease
MY186889A (en) Oral care composition
PH12015502304A1 (en) Use of pidotimod to treat irritable bowel syndrome